Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in Advanced Squamous Cell Cancers
This clinical trial represents a step in developing potential treatments for advanced cancer.
This clinical trial represents a step in developing potential treatments for advanced cancer.
Auto-scored: The event is a medical trial announcement with no indication of AI-related risk.